Literature DB >> 3664236

Node dissection in gastric cancer.

X de Aretxabala1, K Konishi, Y Yonemura, K Ueno, M Yagi, M Noguchi, K Miwa, I Miyazaki.   

Abstract

Three hundred patients who underwent absolute and relative curative gastrectomy and lymph node dissection for gastric cancer were reviewed with respect to postoperative mortality; proportion of patients with node involvement according to the extent of dissection; number of metastatic nodes dissected according to the extent of dissection; accuracy of macroscopic evaluation of node involvement and microscopic node involvement according to tumour location. If more nodes were dissected the proportion of patients with node involvement and the total number of metastatic nodes increased; conversely within R0 and R3 the extent of dissection did not affect postoperative survival. Finally when the presence and extent of node involvement was only macroscopically evaluated, the patients were classified incorrectly in 9.5 per cent of the N0 group and 20.2 per cent of the N1 group. The data suggest that lymph node dissection may be useful in the treatment of gastric cancer, and within the extent studied the employment of this procedure does not affect the postoperative mortality.

Entities:  

Mesh:

Year:  1987        PMID: 3664236     DOI: 10.1002/bjs.1800740904

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  20 in total

1.  Lymph node metastases of gastric cancer. General pattern in 1931 patients.

Authors:  K Maruyama; P Gunvén; K Okabayashi; M Sasako; T Kinoshita
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

2.  Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach.

Authors:  C W Wu; M C Hsieh; S S Lo; S H Tsay; A F Li; W Y Lui; F K P'eng
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Does the extent of lymph node dissection affect the postoperative survival of patients with gastric cancer and disseminating peritoneal metastasis?

Authors:  M Maeta; A Sugesawa; M Ikeguchi; S Tsujitani; H Yamashiro; S Shibata; A Kondo; N Kaibara
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

4.  Lymph node metastasis in patients with gastric cancer: a multi-modality, morphologic and functional imaging study.

Authors:  Jinman Zhong; Weiwei Zhao; Fang Ren; Shun Qi; Xifu Wang; Tianchu Lv; Zhanliang Su; Hong Yin; Jing Ren; Yi Huan
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 5.  How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.

Authors:  Christina Kim; Karen Mulder; Jennifer Spratlin
Journal:  Oncologist       Date:  2014-08-20

6.  A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma.

Authors:  Satoshi Murahashi; Daisuke Takahari; Takeru Wakatsuki; Naoki Fukuda; Takashi Ichimura; Mariko Ogura; Masato Ozaka; Eiji Shinozaki; Izuma Nakayama; Tomohiro Matsushima; Hiroki Osumi; Keisho Chin; Kensei Yamaguchi
Journal:  Int J Clin Oncol       Date:  2017-09-14       Impact factor: 3.402

7.  The operative mortality rate in the R3 total gastrectomy group.

Authors:  M Noguchi
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969

8.  Evaluation of internal target volume in patients undergoing image-guided intensity modulated adjuvant radiation for gastric cancers.

Authors:  A Aggarwal; S Chopra; S N Paul; R Engineer; S K Srivastava
Journal:  Br J Radiol       Date:  2013-11-28       Impact factor: 3.039

9.  Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer? A result based on a hospital population of two decades as taking D2 surgery for reference.

Authors:  Hao Zhang; Caigang Liu; Di Wu; Yi Meng; Ruonan Song; Ping Lu; Shubao Wang
Journal:  BMC Cancer       Date:  2010-06-20       Impact factor: 4.430

10.  Race and correlations between lymph node number and survival for patients with gastric cancer.

Authors:  Rebecca Nelson; Eun Bi Ko; Amanda Arrington; Wendy Lee; Jae Kim; Julio Garcia-Aguilar; Joseph Kim
Journal:  J Gastrointest Surg       Date:  2013-01-04       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.